Recombinant nucleocapsid-based ELISA for detection of IgG antibody to Rift Valley fever virus in African buffalo

Veterinary Microbiology

Volumn 127, Issue 1-2, 2008, Pages 21-28

  Paweska, Janusz T ^a   van Vuren, Petrus Jansen ^a   Kemp, Alan ^a   Buss, Peter ^b   Bengis, Roy G ^b   Gakuya, Francis ^c   Breiman, Robert F ^d   Njenga, M Kariuki ^d   Swanepoel, Robert ^a  

^a NATIONAL INSTITUTE FOR COMMUNICABLE DISEASES   (South Africa)

^b KRUGER NATIONAL PARK   (South Africa)

^c KENYA WILDLIFE SERVICE   (Kenya)

^d KENYA MEDICAL RESEARCH INSTITUTE   (Kenya)

Author keywords

African buffalo; IgG antibody; Recombinant nucleocapsid ELISA; Rift Valley fever virus; Validation

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; NEUTRALIZING ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY DETECTION; ARTICLE; BUFFALO; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; ENZYME LINKED IMMUNOSORBENT ASSAY; KENYA; NONHUMAN; RECEIVER OPERATING CHARACTERISTIC; RIFT VALLEY FEVER BUNYAVIRUS; SOUTH AFRICA; VIRUS INFECTION; VIRUS NEUTRALIZATION; VIRUS NUCLEOCAPSID;

AFRICA; ANIMALS; ANTIBODIES, VIRAL; BUFFALOES; ENZYME-LINKED IMMUNOSORBENT ASSAY; IMMUNOGLOBULIN G; NUCLEOCAPSID; RECOMBINANT PROTEINS; REPRODUCIBILITY OF RESULTS; RIFT VALLEY FEVER; RIFT VALLEY FEVER VIRUS; SENSITIVITY AND SPECIFICITY;

ANIMALIA; RIFT VALLEY FEVER VIRUS; SYNCERUS CAFFER;

EID: 37249094033     PISSN: 03781135     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vetmic.2007.07.031     Document Type: Article

References (42)

1. Anderson E.C., and Rowe L.W. The prevalence of antibody to the viruses of bovine virus diarrhoea, bovine herpes virus 1, Rift Valley fever, ephemeral fever and bluetongue and to Leptospira sp. In free-ranging wildlife in Zimbabwe. Epidemiol. Infect. 121 (1998) 441-449
2. Barnard B.J.H. Rift Valley fever vaccine-antibody and immune response in cattle to a live and an inactivated vaccine. J. S. Afr. Vet. Assoc. 50 (1979) 155-157
3. Bishop D.H., Calisher C.H., Casals J., Chumakov M.P., Gaidamovich S.Y., Hannoun C., Lvov D.K., Marshall I.D., Oker-Blom N., Pettersson R.F., Porterfield J.S., Russell P.K., Shope R.E., and Westaway E.G. Bunyaviridae. Intervirology 14 (1980) 125-143
4. Brenner H., and Gefeller O. Variation of sensitivity, specificity, likelihood rations and predictive values with disease prevalence. Stat. Med. 16 (1997) 981-991
5. Centers for Disease Control and Prevention, 2007. Rift Valley fever outbreak in Kenya, November 2006-January 2007. MMWR Morb. Mortal. Wkly. Rep. 2007, 56, 73-76.
6. Daubney R., and Hudson J.R. Rift Valley fever. Lancet 1 (1932) 611-612
7. Davies F.G. Observations on the epidemiology of Rift Valley fever in Kenya. J. Hyg. 7 (1975) 561-573
8. Davies F.G., and Karstad L. Experimental infection of the African buffalo with the virus of Rift Valley fever. Trop. Anim. Health Prod. 13 (1981) 815-816
9. Deshpande S.S. Assay development, evaluation and validation. In: Deshpande (Ed). Enzyme Immunoassays. From Concept to Product Development (1996), Chapman & Hall, New York 275-359
10. Fafetine J.M., Tijhaar E., Paweska J.T., Newes L.C.B.G., Hendriks J., Swanepoel R., Coetzer J.A.W., Egbering H.F., and Rutten V.P.M.G. Cloning and expression of Rift Valley fever virus nucleocapsid (N) protein and evaluation of a N-protein based indirect ELISA for the detection of specific IgG and IgM antibodies in domestic ruminants. Vet. Microbiol. 121 (2007) 29-38
11. Fischer-Tenhagen C., Hamblin C., Quandt S., and Frolich K. Serosurvey for selected infectious disease agents in free-ranging black and white rhinoceros in Africa. J. Wildl. Dis. 36 (2000) 316-323
12. Gauliard N., Billecocq A., Flick R., and Bouloy M. Rift Valley fever virus noncoding regions of L, M and S segments regulate RNA synthesis. Virology 351 (2006) 170-179
13. Greiner M. Two-graph receiver operating characteristics (TG-ROC)-a Microsoft-Excel template for the selection of cut-off values in diagnostic tests. J. Immunol. Methods. 185 (1995) 145-146
14. Greiner M. Two-graph receiver operating characteristics (TG-ROC): update version supports optimisation of cut-off values that minimize overall misclassification costs. J. Immunol. Methods. 191 (1996) 93-94
15. Greiner M., Sohr D., and Göbel P. A modified ROC analysis for the selection of cut-off values and the definition of intermediate results of serodiagnostic tests. J. Immunol. Methods. 185 (1995) 123-132
16. Jacobson R.H. Validation of serological assays for diagnosis of infectious diseases. Rev. Sci. Tech. 17 (1998) 469-486
17. Jacobson R.H. Principles of validation of diagnostic assays for infectious diseases. OIE Manual of Standards for Diagnostic Tests and Vaccines. 4th ed. (2000), Office International des Epizooties, Paris, France pp. 10-17, Jacobson
18. Jansen van Vuren P., Paweska J.T., Potgieter A.C., and Van Dijk A.A. Preparation and evaluation of a recombinant Rift Valley fever virus N-protein for the detection of IgG and IgM antibodies in humans and animals. J. Virol. Methods 140 (2007) 106-114
19. Jupp P.G., Kemp A., Grobbelaar A., Leman P., Burt F.J., Alahmed A.M., Al Mujalli D., Al Khamess M., and Swanepoel R. The 2000 epidemic of Rift Valley fever in Saudi Arabia: mosquito vector studies. Med. Vet. Entomol. 16 (2002) 245-252
20. Kitchen S.F. Laboratory infections with the virus of Rift Valley fever. Am. J. Trop. Med. Hyg. 14 (1934) 547-564
21. Lim D.V., Simpson J.M., Kearns E.A., and Kramer M.F. Current and developing technologies for monitoring agents of bioterrorism and biowarfare. Clin. Microbiol. Rev. 18 (2005) 583-607
22. Magurano F., and Nicoletti L. Humoral response in Toscana virus acute neurologic disease investigated by viral-protein-specific immmunoassays. Clin. Diagn. Lab. Immunol. 6 (1999) 55-60
23. McIntosh B.M., Russel D., Dos Santos I., and Gear J.H.S. Rift Valley fever in humans in South Africa. S. Afr. Med. J. 58 (1980) 803-806
24. Paweska J.T., Burt F.J., Anthony F., Simith S.J., Grobblaar A.A., Croft J.E., Ksiazek T., and Swanepoel R. IgG-sandwich and IgM-capture enzyme-linked immunosorbent assay for detection of antibody to Rift Valley fever in domestic ruminants. J. Virol. Methods 113 (2003) 103-112
25. Paweska J.T., Smith S.J., Wright I.M., Williams R., Cohen A.S., Van Dijk A.A., Grobbelaar A.A., Croft J.E., Swanepoel R., and Gerdes G.H. Indirect enzyme-linked immunosorbent assay for the detection of antibody against Rift Valley fever virus in domestic and wild ruminant sera. Onderstepoort J. Vet. Res. 70 (2003) 49-64
26. Paweska J.T., Mortimer E., Leman P.A., and Swanepoel R. An inhibition enzyme-linked immunosorbent assay for the detection of antibody to Rift Valley fever in humans, domestic and wild ruminants. J. Virol. Methods 127 (2005) 10-18
27. Peters C.J. Are hemorrhagic viruses practical agents for biological terrorism?. In: Scheld W.M., and Craig W.A. (Eds). Emerging Infections (2000), ASM Press, Washington, DC 203-211
28. Purse B.V., Mellor P.S., Rogers D.J., Samuel A.R., Mertens P.P.C., and Baylis M. Climate change and the recent emergence of bluetongue in Europe. Nat. Rev. Microbiol. 3 (2005) 171-181
29. Saunders G.C., Clinard E.H., Bartlett M.L., and Sanders W.M. Application of the indirect enzyme-labeled antibody microtest to the detection and surveillance of animal diseases. J. Infect. Dis. Suppl. 136 (1977) S258-S266
30. Schrijver R.S., and Kramps J.A. Critical factors affecting the diagnostic reliability of enzyme-linked immunosorbent assay formats. Rev. Sci. Tech. 17 (1998) 550-661
31. Schwarz T.F., Gilch S., Pauli C., and Jager G. Immunoblot detection of antibodies to Toscana virus. J. Med. Virol. 49 (1996) 83-86
32. Sidwell R.W., and Smee D.F. Viruses of the Bunya- and Togaviridae families: potential as bioterrorism agents and means of control. Antiviral Res. (2003) 101-111
33. Smithburn K.C., Mahaffy A.F., Haddow A.J., Kitchen S.F., and Smith J.F. Rift Valley fever accidental infections among laboratory workers. J. Immunol. 62 (1949) 213-227
34. Swanepoel R. Studies on the epidemiology of Rift Valley fever. J. S. Afr. Vet. Ass. 3 (1976) 42-52
35. Swanepoel R., and Coetzer J.A.W. Rift Valley fever. In: Coetzer J.A.W., and Tustin R.C. (Eds). Infectious Diseases of Livestock (2004), Oxford University Press, Cape Town pp. 2, 1037-1070
36. Swanepoel R., Struthers J.K., Erasmus M.J., Shepherd S.P., McGillivray G.M., Erasmus B.J., and Barnard B.J.H. Comparison of techniques for demonstrating antibodies to Rift Valley fever virus. J. Hyg. 97 (1986) 317-329
37. Swanepoel R., Struthere J.K., Erasmus M.J., Shepherd S.P., McGillivry G.M., Shepherd A.J., Hummitzsch D.E., Erasmus B.J., and Barnard B.J.H. Comparative pathogenicity and antigenic cross-reactivity of Rift Valley fever and other African phleboviruses in sheep. J. Hyg. 97 (1986) 331-346
38. Turrel M.J., Bailey C.L., and Beaman J.R. Vector competence of a Houston, Texas strain of Aedes albopictus for Rift Valley fever virus. J. Am. Mosq. Control Assoc. 4 (1998) 94-98
39. Tyler J.W., and Cullor J.S. Titers, tests, and truisms: rational interpretation of diagnostic serologic testing. J. Am. Vet. Med. Assoc. 194 (1989) 1550-1558
40. Vapalahti O., Kallio-Kokko H., Narvanen A., Julkunen I., Lundkvist A., Plyusnin A., Lehvaslaiho H., Brummer-Korvenkontio M., Vaheri A., and Lankinen H. Human B-cell epitopes of Puumala virus nucleocapsid protein, the major antigen in early serological response. J. Med. Virol. 46 (1995) 293-303
41. Vizard A.L., Anderson G.A., and Gasser R.B. Determination of the optimum cut-off value of a diagnostic test. Prev. Vet. Med. 10 (1990) 137-143
42. Wright P.F., Nilsson E., Van Rooij E.M.A., Lelenta M., and Jeggo M.H. Standardisation and validation of enzyme-linked immunosorbent assay techniques for the detection of antibody in infectious disease diagnosis. Rev. Sci. Tech. 12 (1993) 435-450